LAVA Therapeutics Changes Certifying Accountant
| Field | Detail |
|---|---|
| Company | Lava Therapeutics NV |
| Form Type | 8-K |
| Filed Date | May 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: auditor-change, regulatory-filing
TL;DR
LAVA Therapeutics swapped auditors, filing 8-K on 5/23/25.
AI Summary
LAVA Therapeutics N.V. filed an 8-K on May 23, 2025, reporting a change in its certifying accountant as of May 20, 2025. The filing also includes financial statements and exhibits. The company, previously known as LAVA Therapeutics BV, is incorporated in The Netherlands and operates in the Pharmaceutical Preparations sector.
Why It Matters
A change in a company's auditor can sometimes signal underlying financial concerns or a desire for a fresh perspective on financial reporting.
Risk Assessment
Risk Level: low — This filing solely reports a change in the company's auditor, which is a routine administrative event.
Key Players & Entities
- LAVA Therapeutics N.V. (company) — Registrant
- May 20, 2025 (date) — Date of earliest event reported
- May 23, 2025 (date) — Filing date
- LAVA Therapeutics BV (company) — Former company name
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a change in LAVA Therapeutics N.V.'s certifying accountant, effective May 20, 2025.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted to the SEC on May 23, 2025.
What was LAVA Therapeutics N.V.'s former name?
LAVA Therapeutics N.V.'s former name was LAVA Therapeutics BV.
In which jurisdiction is LAVA Therapeutics N.V. incorporated?
LAVA Therapeutics N.V. is incorporated in The Netherlands.
What is LAVA Therapeutics N.V.'s primary industry classification?
LAVA Therapeutics N.V.'s primary industry classification is Pharmaceutical Preparations [2834].
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 23, 2025 regarding LAVA Therapeutics NV.